These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23399363)

  • 1. A simple approach to confirm the presence of anti-D in sera with presumed anti-D+C specificity.
    Baía F; Muñiz-Diaz E; Boto N; Salgado M; Montero R; Ventura T; Sousa H; Alves B; Nogués N; Koch C
    Blood Transfus; 2013 Jul; 11(3):449-51. PubMed ID: 23399363
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-D alloimmunization propensity cannot be determined without information on D antigen exposure.
    Yazer MH; Triulzi DJ
    Transfusion; 2012 Sep; 52(9):2069-70; author reply 2070. PubMed ID: 22946977
    [No Abstract]   [Full Text] [Related]  

  • 3. Allo- and autoanti-D in weak D types and in partial D.
    Flegel WA; Denomme GA
    Transfusion; 2012 Sep; 52(9):2067-9; author reply 2070. PubMed ID: 22946976
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficient and safe definition of the rhesus-negative donor on the olympus PK 7200 without the indirect antiglobulin test for weak D.
    Mertens G; Muylle L
    Vox Sang; 1996; 70(4):237-8. PubMed ID: 9123933
    [No Abstract]   [Full Text] [Related]  

  • 5. Some observations on D antigen expression of D-positive and 'weak D-positive' red cells as assessed by flow cytometry.
    Nelson M; Barrow LA; Popp H; Gibson J
    Vox Sang; 1995; 69(2):152-4. PubMed ID: 8585204
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and quantification of anti-D, -C and -G in alloimmunized pregnant women.
    Maley M; Babb R; Chapman CE; Fitzgerald J; Cavanagh G
    Transfus Med; 2001 Dec; 11(6):443-6. PubMed ID: 11851942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The determination of the Rh factor with anti-D monoclonal antibodies on a flat surface].
    Zavgorodniĭ GN; Pogodina TL; Pichugina MN
    Gematol Transfuziol; 1993 Jan; 38(1):45-6. PubMed ID: 8020708
    [No Abstract]   [Full Text] [Related]  

  • 8. Policies and procedures related to weak D phenotype testing and Rh immune globulin administration. Results from supplementary questions to the Comprehensive Transfusion Medicine Survey of the College of American Pathologists.
    Domen RE
    Arch Pathol Lab Med; 2000 Aug; 124(8):1118-21. PubMed ID: 10923069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case study of leukemia with irregular anti-Ce IgG antibody].
    Zhong GP; Shi W; Liao KM; Bi JQ; Sun Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):211-2. PubMed ID: 15841159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do I manage Rh typing in obstetric patients?
    Haspel RL; Westhoff CM
    Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
    [No Abstract]   [Full Text] [Related]  

  • 11. Significantly enhanced testing sensitivities of automated ORTHO VISION analyzers detect weak D phenotypes.
    Peterson R; Young PP
    Transfusion; 2017 Nov; 57(11):2565-2566. PubMed ID: 29105829
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Erytra® fully automated analyser for Routine Use in Transfusion Laboratory.
    Chang C; Brown M; Davies L; Pointon L; Brown R; Barker D
    Transfus Med; 2014 Feb; 24(1):33-8. PubMed ID: 24188135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNB: a partial D with anti-D frequent in Central Europe.
    Wagner FF; Eicher NI; Jørgensen JR; Lonicer CB; Flegel WA
    Blood; 2002 Sep; 100(6):2253-6. PubMed ID: 12200394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A confusion in antibody identification: anti-D production after anti-hrB.
    Lomas-Francis C; Yomtovian R; McGrath C; Walker PS; Reid ME
    Immunohematology; 2007; 23(4):158-60. PubMed ID: 18284306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a rapid antenatal Rh test on laboratory testing.
    Smart EA; Milner LV
    S Afr Med J; 1993 Dec; 83(12):922. PubMed ID: 8115932
    [No Abstract]   [Full Text] [Related]  

  • 16. When is an anti-D antibody not an anti-D antibody?
    Merron BM; Maguire K; Morris K
    Transfus Med; 2015 Apr; 25(2):115-7. PubMed ID: 25925731
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the gel system for ABO grouping and D typing.
    Langston MM; Procter JL; Cipolone KM; Stroncek DF
    Transfusion; 1999 Mar; 39(3):300-5. PubMed ID: 10204594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-D human immunoglobulin test].
    Kajiwara M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():795-7. PubMed ID: 20942192
    [No Abstract]   [Full Text] [Related]  

  • 19. Addendum for guidelines for blood grouping and red cell antibody testing during pregnancy. BCSH Transfusion Task Force.
    Bruce M; Chapman JF; Duguid J; Kelsey P; Knowles S; Murphy M; Williamson L
    Transfus Med; 1999 Mar; 9(1):99. PubMed ID: 10428575
    [No Abstract]   [Full Text] [Related]  

  • 20. The British Standard for (European Conformity[CE] Marked) Anti-D: Its rarely discussed but important role in quantitating anti-D in patient plasma.
    Fox B; Hockley J; Studholme L
    Transfus Med; 2020 Feb; 30(1):75-77. PubMed ID: 31769103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.